Mannkind (MNKD) Non Operating Income (2010 - 2026)
Mannkind (MNKD) reported Non Operating Income of -$14.7 million for Q1 2026, down 69.42% year-over-year from -$48.1 million in Q1 2025, and down 163.52% quarter-over-quarter from $23.1 million in Q4 2025.
Mannkind (MNKD) Non Operating Income (2010 - 2026) Analysis & Trends
Mannkind (MNKD) has 17 years of Non Operating Income data on file, last reported at -$14.7 million in Q1 2026.
- Non Operating Income for Q1 2026 came in at -$14.7 million, down 69.42% year-over-year; the trailing twelve-month figure through Mar 2026 was -$7.0 million (down 149.72% YoY), and the FY2025 annual result was -$1.0 million, down 3253.12% from the prior year.
- Non Operating Income fell to -$14.7 million in Q1 2026 per MNKD's latest filing, from $23.1 million in the prior quarter.
- Over five years, Non Operating Income peaked at $24.1 million in Q4 2024 and troughed at -$19.3 million in Q4 2023.
- A 5-year average of -$3.2 million and a median of -$4.7 million in 2022 frame the typical range for Non Operating Income.
- The sharpest annual moves came in 2022 and 2023: Non Operating Income sank 24582.86% in 2022, then surged 253.62% in 2023.
- A 5-year view of Non Operating Income shows it stood at $105000.0 in 2022, then sank by 18520.0% to -$19.3 million in 2023, then jumped by 224.35% to $24.1 million in 2024, then slipped by 3.78% to $23.1 million in 2025, then sank by 163.52% to -$14.7 million in 2026.
- Business Quant data shows MNKD's Non Operating Income at -$14.7 million in Q1 2026, $23.1 million in Q4 2025, and -$11.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 5.75 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 444,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 9.35 Mn |
| 10 | Mannkind | 1.21 Bn | 1.08 Bn | 82.66 Mn | -14.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -14.70 Mn |
| Dec 31, 2025 | 23.14 Mn |
| Sep 30, 2025 | -11.12 Mn |
| Jun 30, 2025 | -4.36 Mn |
| Mar 31, 2025 | -8.68 Mn |
| Dec 31, 2024 | 24.05 Mn |
| Sep 30, 2024 | 110,000.00 |
| Jun 30, 2024 | -18.30 Mn |
| Mar 31, 2024 | -5.83 Mn |
| Dec 31, 2023 | -19.34 Mn |
| Sep 30, 2023 | 318,000.00 |
| Jun 30, 2023 | -6.99 Mn |
| Mar 31, 2023 | 111,000.00 |
| Dec 31, 2022 | 105,000.00 |
| Sep 30, 2022 | -207,000.00 |
| Jun 30, 2022 | -8.57 Mn |
| Mar 31, 2022 | -4.74 Mn |
| Dec 31, 2021 | -33.66 Mn |
| Sep 30, 2021 | 1,000.00 |
| Jun 30, 2021 | 35,000.00 |